{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:48:11Z","timestamp":1790714891705,"version":"4.1.0"},"reference-count":362,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007847","name":"Jilin Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["YDZJ202401140ZYTS"],"award-info":[{"award-number":["YDZJ202401140ZYTS"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116780","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:04:46Z","timestamp":1778087086000},"page":"116780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects"],"prefix":"10.1016","volume":"182","author":[{"given":"Shuo","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116780_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries\/territories from 1990 to 2019","volume":"9","author":"Ou","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.intimp.2026.116780_bb0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaneurol.2016.0947","article-title":"Time trends in the incidence of Parkinson disease","volume":"73","author":"Savica","year":"2016","journal-title":"JAMA. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"Bmj"},{"key":"10.1016\/j.intimp.2026.116780_bb0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41746-024-01217-2","article-title":"Digital biomarkers for precision diagnosis and monitoring in Parkinson\u2019s disease","volume":"7","author":"Sun","year":"2024","journal-title":"NPJ. Digit. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","article-title":"Role of dopamine in the pathophysiology of Parkinson\u2019s disease","volume":"12","author":"Zhou","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00415-024-12770-x","article-title":"An update on immune-based alpha-synuclein trials in Parkinson\u2019s disease","volume":"272","author":"Alfaidi","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: a unified framework","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2026.116780_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137183","article-title":"A comprehensive approach to Parkinson\u2019s disease: addressing its molecular, clinical, and therapeutic aspects","volume":"25","author":"Muleiro Alvarez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00702-025-02893-4","article-title":"Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression","volume":"132","author":"Riederer","year":"2025","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.intimp.2026.116780_bb0060","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s42003-025-08997-7","article-title":"MIF downregulation attenuates neuroinflammation via TLR4\/MyD88\/TRAF6\/NF-\u03baB pathway to protect dopaminergic neurons in Parkinson's disease model","volume":"8","author":"Huang","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113938","article-title":"Mechanism of S100A9-mediated astrocyte activation via TLR4\/NF-\u03baB in Parkinson\u2019s disease","volume":"146","author":"Qiao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116780_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087137","article-title":"Revisiting alpha-synuclein pathways to inflammation","volume":"24","author":"Lyra","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbi.2018.12.003","article-title":"TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in vivo model","volume":"76","author":"Campolo","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.116780_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/jnc.14902","article-title":"Are genetic and idiopathic forms of Parkinson\u2019s disease the same disease?","volume":"152","author":"Correia Guedes","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.116780_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113015","article-title":"From mitochondrial dysfunction to neuroinflammation in Parkinson's disease: pathogenesis and mitochondrial therapeutic approaches","volume":"142","author":"Ebadpour","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12962","article-title":"Inflammatory bowel disease induces pathological \u03b1-synuclein aggregation in the human gut and brain","volume":"50","author":"Espinosa-Oliva","year":"2024","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.intimp.2026.116780_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.intimp.2026.116780_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2051-5960-1-2","article-title":"The prion hypothesis in Parkinson\u2019s disease: Braak to the future","volume":"1","author":"Visanji","year":"2013","journal-title":"Acta. Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2026.116780_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson\u2019s disease: the dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0115","first-page":"S281","article-title":"Brain-first versus gut-first Parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0130","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.tips.2012.07.002","article-title":"Inflammation and neurodegeneration: the story 'retolled'","volume":"33","author":"Drouin-Ouellet","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fphar.2018.00417","article-title":"Toll-like receptor 2 signaling and current approaches for therapeutic modulation in synucleinopathies","volume":"9","author":"Caplan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.intimp.2026.116780_bb0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116780_bb0150","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson's disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0155","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","article-title":"Alpha-synuclein in peripheral tissues in Parkinson\u2019s disease","volume":"10","author":"Ma","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-021-01136-3","article-title":"Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson\u2019s disease","volume":"9","author":"Reyes","year":"2021","journal-title":"Acta. Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2026.116780_bb0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ane.12247","article-title":"Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson\u2019s disease - a systematic review","volume":"130","author":"Malek","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.intimp.2026.116780_bb0170","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/pharmrev.123.001111","article-title":"Posttranslational modifications of \u03b1-synuclein, their therapeutic potential, and crosstalk in health and neurodegenerative diseases","volume":"76","author":"Hassanzadeh","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2026.116780_bb0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"\u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.116780_bb0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2014.07.003","article-title":"A cell culture model for monitoring \u03b1-synuclein cell-to-cell transfer","volume":"77","author":"Reyes","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032477","article-title":"The Interplay between \u03b1-Synuclein and Microglia in \u03b1-Synucleinopathies","volume":"24","author":"Deyell","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-023-00372-y","article-title":"\u03b1-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis","volume":"12","author":"Wang","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010360","article-title":"Alpha-synuclein contribution to neuronal and glial damage in Parkinson's disease","volume":"25","author":"Saramowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s12276-021-00562-6","article-title":"Effects of innate immune receptor stimulation on extracellular \u03b1-synuclein uptake and degradation by brain resident cells","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-020-01776-7","article-title":"Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain","volume":"17","author":"Rostami","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116780_bb0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral atransplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm1752","article-title":"Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years","volume":"14","author":"Mendez","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.1132","article-title":"Lewy bodies and parkinsonism in families with parkin mutations","volume":"50","author":"Farrer","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0225","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/mds.23637","article-title":"Milestones in PD genetics","volume":"26","author":"Gasser","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116780_bb0230","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301253R","article-title":"Prodromal Parkinson's disease and the catecholaldehyde hypothesis: insight from olfactory bulb organotypic cultures","volume":"37","author":"Bagnoli","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2026.116780_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/REVNEURO.1997.8.1.29","article-title":"The neuroimmune hypothesis in Parkinson's disease","volume":"8","author":"Kuhn","year":"1997","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0240","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1073858415574600","article-title":"The Parkinson disease mitochondrial hypothesis: where are we at?","volume":"22","author":"Franco-Iborra","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.intimp.2026.116780_bb0245","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","article-title":"The oxidant stress hypothesis in Parkinson's disease: evidence supporting it","volume":"32","author":"Fahn","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115999","article-title":"The catecholaldehyde hypothesis for the pathogenesis of catecholaminergic neurodegeneration: what we know and what we do not know","volume":"22","author":"Goldstein","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0255","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2026.116780_bb0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.20587","article-title":"Lewy body Parkinson\u2019s disease in a large pedigree with 77 Parkin mutation carriers","volume":"58","author":"Pramstaller","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0265","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.116780_bb0270","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24129903","article-title":"Microglia and astroglia-the potential role in neuroinflammation induced by pre- and neonatal exposure to lead (Pb)","volume":"24","author":"G\u0105ssowska-Dobrowolska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0285","doi-asserted-by":"crossref","first-page":"1672241","DOI":"10.3389\/fimmu.2026.1672241","article-title":"TLR4\/NF-\u03baB signaling-mediated neuroinflammation is associated with gut microbiota dysbiosis in a mouse model of Parkinson's disease","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0290","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/14728222.2019.1676416","article-title":"Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders","volume":"23","author":"Leitner","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2026.116780_bb0295","doi-asserted-by":"crossref","first-page":"2899271","DOI":"10.1155\/2023\/2899271","article-title":"TIRAP, TRAM, and toll-like receptors: the untold story","volume":"2023","author":"Lannoy","year":"2023","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2026.116780_bb0300","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1093\/gbe\/evz266","article-title":"Evolutionary history of the toll-like receptor gene family across vertebrates","volume":"12","author":"Liu","year":"2020","journal-title":"Genome. Biol. Evol."},{"key":"10.1016\/j.intimp.2026.116780_bb0305","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3389\/fimmu.2018.02379","article-title":"Pattern recognition receptors and the host cell death molecular machinery","volume":"9","author":"Amarante-Mendes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0310","doi-asserted-by":"crossref","first-page":"1227833","DOI":"10.3389\/fimmu.2023.1227833","article-title":"Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy","volume":"14","author":"Chakraborty","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.intimp.2026.116780_bb0320","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding Toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116780_bb0325","article-title":"Unraveling the complexities of toll-like receptors: from molecular mechanisms to clinical applications","volume":"25","author":"Chen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306399120","article-title":"Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2","volume":"120","author":"Bai","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116780_bb0335","doi-asserted-by":"crossref","first-page":"1049340","DOI":"10.3389\/fimmu.2022.1049340","article-title":"Toll-like receptor-targeted anti-tumor therapies: Advances and challenges","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0340","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/glia.20699","article-title":"Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice","volume":"56","author":"Bettoni","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116780_bb0345","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb0355","doi-asserted-by":"crossref","first-page":"1370042","DOI":"10.3389\/fcell.2024.1370042","article-title":"TRIF-dependent signaling and its role in liver diseases","volume":"12","author":"Hu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb0360","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","article-title":"CD14 controls the LPS-induced endocytosis of Toll-like receptor 4","volume":"147","author":"Zanoni","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116780_bb0365","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12964-025-02149-4","article-title":"An examination of the LPS-TLR4 immune response through the analysis of molecular structures and protein-protein interactions","volume":"23","author":"Luo","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2026.116780_bb0370","doi-asserted-by":"crossref","first-page":"13128","DOI":"10.1038\/srep13128","article-title":"The architecture of the TIR domain signalosome in the toll-like receptor-4 signaling pathway","volume":"5","author":"Guven-Maiorov","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119155","article-title":"Toll-like receptor 4: an attractive therapeutic target for acute kidney injury","volume":"271","author":"Jha","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0380","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1111\/febs.70042","article-title":"TAK1 at the crossroads of multiple regulated cell death pathways: from molecular mechanisms to human diseases","volume":"292","author":"Huang","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.intimp.2026.116780_bb0385","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116780_bb0390","article-title":"TAK1: a molecular link between liver inflammation, fibrosis, steatosis, and carcinogenesis","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb0395","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2011.12.010","article-title":"TAK1 negatively regulates NF-\u03baB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils","volume":"36","author":"Ajibade","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116780_bb0400","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","article-title":"Regulating IRFs in IFN driven disease","volume":"10","author":"Jefferies","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0405","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1038\/s44319-025-00444-2","article-title":"TLR4 endocytosis and endosomal TLR4 signaling are distinct and independent outcomes of TLR4 activation","volume":"26","author":"Schultz","year":"2025","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb0410","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116780_bb0415","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.it.2013.03.007","article-title":"Cell type-specific function of TAK1 in innate immune signaling","volume":"34","author":"Ajibade","year":"2013","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0420","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1074\/jbc.M117.796631","article-title":"Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKK\u03f5-IRF3 axis activation","volume":"293","author":"Tsukamoto","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb0425","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb0430","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpeds.2010.12.042","article-title":"STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease","volume":"158","author":"Nadeau","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.intimp.2026.116780_bb0435","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3389\/fimmu.2018.03047","article-title":"IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies","volume":"9","author":"Mogensen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0440","article-title":"Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease","volume":"18","author":"Drouin-Ouellet","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0445","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","article-title":"Neuroinflammation and protein pathology in Parkinson's disease dementia","volume":"8","author":"Kouli","year":"2020","journal-title":"Acta. Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2026.116780_bb0450","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1038\/srep14764","article-title":"Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson\u2019s disease","volume":"5","author":"Shin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb0455","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70020","article-title":"IGF2-reprogrammed macrophages ameliorate the inflammatory response and protect against the neuroinflammatory process in Parkinson\u2019s disease models","volume":"24","author":"Grunenwald","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.intimp.2026.116780_bb0460","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/mds.28052","article-title":"Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease","volume":"35","author":"Cirstea","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116780_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101368","article-title":"Toll-like receptor 4 is upregulated in Parkinson's disease patients and co-localizes with pSer129\u03b1Syn: a possible link with the pathology","volume":"12","author":"Conte","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116780_bb0470","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbi.2020.01.018","article-title":"Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson\u2019s disease","volume":"87","author":"Wijeyekoon","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.116780_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116780_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.948","article-title":"High expression of the HMGB1-TLR4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging","volume":"8","author":"Yang","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.intimp.2026.116780_bb0485","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2022.01.005","article-title":"Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition","volume":"101","author":"Konstantin Nissen","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.116780_bb0490","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2026.116780_bb0495","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s10072-015-2227-9","article-title":"Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population","volume":"36","author":"Zhao","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0500","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jocn.2018.12.002","article-title":"Interaction between toll-like receptor 4 (TLR4) gene and alcohol drinking on Parkinson's disease risk in Chinese Han population","volume":"62","author":"Li","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.603849","article-title":"Single nucleotide polymorphisms associated with gut homeostasis influence risk and age-at-onset of Parkinson\u2019s disease","volume":"12","author":"Gorecki","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0510","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","article-title":"Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease","volume":"56","author":"Kim","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2026.116780_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114972","article-title":"Astragaloside IV ameliorates Parkinson's disease by inhibiting TLR4\/NF-\u03baB-dependent neuroinflammation","volume":"160","author":"Yang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2013.04.020","article-title":"Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson\u2019s rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation","volume":"331","author":"Kuruvilla","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0525","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11910-008-0045-7","article-title":"Value of genetic models in understanding the cause and mechanisms of Parkinson\u2019s disease","volume":"8","author":"Moore","year":"2008","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb0530","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105215","article-title":"Role of toll-like receptor 4 and sex in 6-hydroxydopamine-induced behavioral impairments and neurodegeneration in mice","volume":"151","author":"Somensi","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.intimp.2026.116780_bb0540","doi-asserted-by":"crossref","first-page":"3175214","DOI":"10.1155\/2018\/3175214","article-title":"Aqueous extract of dendropanax morbiferus leaves effectively alleviated neuroinflammation and behavioral impediments in MPTP-induced Parkinson\u2019s mouse model","volume":"2018","author":"Park","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2026.116780_bb0545","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0550","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0555","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41401-019-0280-2","article-title":"TLR4 deficiency has a protective effect in the MPTP\/probenecid mouse model of Parkinson\u2019s disease","volume":"40","author":"Shao","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.116780_bb0560","article-title":"Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson\u2019s disease","volume":"15","author":"Guo","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb0565","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12974-023-02782-1","article-title":"Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease","volume":"20","author":"Yu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116780_bb0570","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fnins.2017.00306","article-title":"Influence of estrogen modulation on glia activation in a murine model of Parkinson's disease","volume":"11","author":"Siani","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0575","doi-asserted-by":"crossref","first-page":"1494114","DOI":"10.3389\/fimmu.2025.1494114","article-title":"Ambroxol attenuates detrimental effect of LPS-induced glia-mediated neuroinflammation, oxidative stress, and cognitive dysfunction in mice brain","volume":"16","author":"Ullah","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0580","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.intimp.2026.116780_bb0585","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12031-018-1057-7","article-title":"The potential role of toll-like receptor 4 in mediating dopaminergic cell loss and alpha-synuclein expression in the acute MPTP mouse model of Parkinson's disease","volume":"64","author":"Mariucci","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0590","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","article-title":"Toll-like receptor 4 promotes \u03b1-synuclein clearance and survival of nigral dopaminergic neurons","volume":"179","author":"Stefanova","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2026.116780_bb0595","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy","volume":"22","author":"Stefanova","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116780_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020620","article-title":"Two- and three-dimensional in vitro models of Parkinson\u2019s and Alzheimer\u2019s diseases: state-of-the-art and applications","volume":"26","author":"Solana-Manrique","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0605","doi-asserted-by":"crossref","first-page":"5076740","DOI":"10.1155\/2016\/5076740","article-title":"TLR4 signaling in MPP+-induced activation of BV-2 cells","volume":"2016","author":"Zhou","year":"2016","journal-title":"Neural. Plast."},{"key":"10.1016\/j.intimp.2026.116780_bb0610","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10753-023-01918-y","article-title":"Investigating the TLR4\/TAK1\/IRF7 axis in NLRP3-mediated pyroptosis in Parkinson's disease","volume":"47","author":"Quan","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2026.116780_bb0615","doi-asserted-by":"crossref","first-page":"20","DOI":"10.31083\/j.jin2201020","article-title":"SH-SY5Y cell line in vitro models for Parkinson disease research-old practice for new trends","volume":"22","author":"Ioghen","year":"2023","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0620","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0625","first-page":"6956","article-title":"Saikosaponin A mitigates the progression of Parkinson\u2019s disease via attenuating microglial neuroinflammation through TLR4\/MyD88\/NF-\u03baB pathway","volume":"27","author":"Liu","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0630","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212535","article-title":"Cytokine profiling in human iPSC-derived dopaminergic neuronal and microglial cultures","volume":"12","author":"Knappe","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116780_bb0635","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3233\/JAD-2012-120856","article-title":"Additive microglia-mediated neuronal injury caused by amyloid-\u03b2 and bacterial TLR agonists in murine neuron-microglia co-cultures quantified by an automated image analysis using cognition network technology","volume":"31","author":"Sch\u00fctze","year":"2012","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.intimp.2026.116780_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.845930","article-title":"Neuroinflammation upregulated neuronal toll-like receptors 2 and 4 to drive synucleinopathy in neurodegeneration","volume":"13","author":"Chung","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0645","doi-asserted-by":"crossref","first-page":"9999146","DOI":"10.1155\/2021\/9999146","article-title":"Neuroinflammation: an integrating overview of reactive-neuroimmune cell interactions in health and disease","volume":"2021","author":"K\u00f6lliker-Frers","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2026.116780_bb0650","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2026.116780_bb0655","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","article-title":"Neuroinflammation in Parkinson\u2019s disease and its treatment opportunities","volume":"39","author":"\u00c7\u0131nar","year":"2022","journal-title":"Balkan. Med. J."},{"key":"10.1016\/j.intimp.2026.116780_bb0660","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","article-title":"Significant roles of neuroinflammation in Parkinson\u2019s disease: therapeutic targets for PD prevention","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb0665","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","article-title":"Microglia development and function","volume":"32","author":"Nayak","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0670","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10456-024-09911-1","article-title":"Microglia in retinal angiogenesis and diabetic retinopathy","volume":"27","author":"Hu","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.intimp.2026.116780_bb0675","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nn.4631","article-title":"Microglia turnover with aging and in an Alzheimer\u2019s model via long-term in vivo single-cell imaging","volume":"20","author":"F\u00fcger","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0680","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0685","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","article-title":"Microglia: immune and non-immune functions","volume":"54","author":"Borst","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116780_bb0690","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116780_bb0695","article-title":"RRx-001 exerts neuroprotection against LPS-induced microglia activation and neuroinflammation through disturbing the TLR4 pathway","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0700","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.0803590","article-title":"Critical role of TLR4 response in the activation of microglia induced by ethanol","volume":"183","author":"Fernandez-Lizarbe","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0705","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.116780_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson's disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116780_bb0715","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"10","author":"Haruwaka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116780_bb0720","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116780_bb0725","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-019-1538-9","article-title":"Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway","volume":"16","author":"Zusso","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116780_bb0730","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10571-021-01170-8","article-title":"HMGB1 is a potential and challenging therapeutic target for Parkinson's disease","volume":"43","author":"Tian","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.116780_bb0735","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood-brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113310","article-title":"Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma","volume":"329","author":"Devanney","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb0745","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.cell.2019.05.006","article-title":"Single-cell multi-omic integration compares and contrasts features of brain cell identity","volume":"177","author":"Welch","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116780_bb0750","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nn.4547","article-title":"A new fate mapping system reveals context-dependent random or clonal expansion of microglia","volume":"20","author":"Tay","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0755","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2012.05.030","article-title":"Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88\/IKK\/NF-\u03baB signaling pathway in lipopolysaccharide-induced microglia","volume":"692","author":"Zeng","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0760","doi-asserted-by":"crossref","first-page":"eadc9020","DOI":"10.1126\/science.adc9020","article-title":"Molecular basis of astrocyte diversity and morphology across the CNS in health and disease","volume":"378","author":"Endo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116780_bb0765","doi-asserted-by":"crossref","first-page":"1169320","DOI":"10.3389\/fnmol.2023.1169320","article-title":"Neuron-astrocyte omnidirectional signaling in neurological health and disease","volume":"16","author":"Pathak","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0770","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/glia.22683","article-title":"The glia\/neuron ratio: how it varies uniformly across brain structures and species and what that means for brain physiology and evolution","volume":"62","author":"Herculano-Houzel","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116780_bb0775","doi-asserted-by":"crossref","DOI":"10.1042\/AN20110061","article-title":"Astroglial excitability and gliotransmission: an appraisal of Ca2+ as a signalling route","volume":"4","author":"Zorec","year":"2012","journal-title":"ASN. Neuro."},{"key":"10.1016\/j.intimp.2026.116780_bb0780","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: a frontier for new therapies","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116780_bb0785","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168922","article-title":"Metabolic reprogramming of astrocytes in pathological conditions: implications for neurodegenerative diseases","volume":"25","author":"Cal\u00ec","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/biom14101204","article-title":"Astrocyte-mediated neuroinflammation in neurological conditions","volume":"14","author":"Zhao","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116780_bb0795","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104544","article-title":"Opioid-induced microglia reactivity modulates opioid reward, analgesia, and behavior","volume":"135","author":"Green","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2026.116780_bb0805","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0810","article-title":"Neuroprotection and disease modification by astrocytes and microglia in Parkinson disease","volume":"11","author":"Takahashi","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.116780_bb0815","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.2174\/1570159X21666221129121715","article-title":"Bidirectional communication between microglia and astrocytes in neuroinflammation","volume":"21","author":"Bhusal","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb0820","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1073858418783959","article-title":"Microglia-astrocyte crosstalk: an intimate molecular conversation","volume":"25","author":"Jha","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1016\/j.intimp.2026.116780_bb0825","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116780_bb0830","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.490","article-title":"Neuron and microglia\/macrophage-derived FGF10 activate neuronal FGFR2\/PI3K\/Akt signaling and inhibit microglia\/macrophages TLR4\/NF-\u03baB-dependent neuroinflammation to improve functional recovery after spinal cord injury","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb0835","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tins.2016.02.002","article-title":"The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective","volume":"39","author":"Martini-Stoica","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0840","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.intimp.2026.116780_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115383","article-title":"Disorders of the central nervous system: insights from notch and Nrf2 signaling","volume":"166","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116780_bb0850","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tibs.2012.05.002","article-title":"Eaten alive! Cell death by primary phagocytosis: \u2018phagoptosis\u2019","volume":"37","author":"Brown","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031629","article-title":"Extracellular vesicles in the central nervous system: a novel mechanism of neuronal cell communication","volume":"25","author":"Filannino","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0860","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030648","article-title":"Hesperetin, a citrus flavonoid, attenuates lps-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4\/NF-\u03baB signaling","volume":"11","author":"Muhammad","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167714","article-title":"Functional and pathological effects of \u03b1-synuclein on synaptic SNARE complexes","volume":"435","author":"Gao","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb0870","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"\u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb0875","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s10020-025-01208-3","article-title":"The interplay of iron, oxidative stress, and \u03b1-synuclein in Parkinson's disease progression","volume":"31","author":"Chen","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb0880","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040507","article-title":"\u03b1-Synuclein at the presynaptic axon terminal as a double-edged sword","volume":"12","author":"Tan","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116780_bb0885","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s42003-021-02624-x","article-title":"Selectivity of Lewy body protein interactions along the aggregation pathway of \u03b1-synuclein","volume":"4","author":"Leit\u00e3o","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb0890","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in Parkinson\u2019s disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116780_bb0895","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5483\/BMBRep.2022.55.7.073","article-title":"Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease","volume":"55","author":"Yoo","year":"2022","journal-title":"BMB Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb0900","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb0905","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","article-title":"Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein","volume":"40","author":"Lee","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb0910","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899430","article-title":"Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3","volume":"38","author":"Houtman","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2026.116780_bb0915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2026.116780_bb0920","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/glia.23970","article-title":"\u03b1-Synuclein evokes NLRP3 inflammasome-mediated IL-1\u03b2 secretion from primary human microglia","volume":"69","author":"Pike","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116780_bb0925","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0930","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0935","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","article-title":"The multifaceted contributions of mitochondria to cellular metabolism","volume":"20","author":"Spinelli","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb0940","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.emboj.7601972","article-title":"Quality control of mitochondria: protection against neurodegeneration and ageing","volume":"27","author":"Tatsuta","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2026.116780_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery","volume":"11","author":"Picca","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116780_bb0950","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-201981","article-title":"Mitochondria and Parkinson\u2019s disease: clinical, molecular, and translational aspects","volume":"11","author":"Borsche","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb0955","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb0960","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116780_bb0965","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s11011-023-01266-8","article-title":"Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation","volume":"38","author":"Pan","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb0970","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13410","article-title":"Regulation of the NLRP3 inflammasome by autophagy and mitophagy","volume":"329","author":"Gupta","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.116780_bb0975","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.4049\/jimmunol.1701723","article-title":"Cutting edge: mitochondrial assembly of the NLRP3 inflammasome complex is initiated at priming","volume":"200","author":"Elliott","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb0980","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1021\/acschemneuro.5c00035","article-title":"Corilagin attenuates neuronal apoptosis and ferroptosis of Parkinson's disease through regulating the TLR4\/Src\/NOX2 signaling pathway","volume":"16","author":"Lei","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb0985","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41380-023-02251-4","article-title":"Mitochondrial DNA damage triggers spread of Parkinson\u2019s disease-like pathology","volume":"28","author":"Tresse","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.intimp.2026.116780_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073069","article-title":"Mitochondrial DNA in exercise-mediated innate immune responses","volume":"26","author":"Wen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb0995","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/JLB.3MR0118-003R","article-title":"Innate immunity and cellular senescence: the good and the bad in the developmental and aged brain","volume":"103","author":"Santoro","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb1000","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","article-title":"Gut microbiome and Parkinson's disease: perspective on pathogenesis and treatment","volume":"50","author":"Salim","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116780_bb1010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116780_bb1015","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00797-20","article-title":"Short-chain fatty acid-producing gut microbiota is decreased in Parkinson's disease but not in rapid-eye-movement sleep behavior disorder","volume":"5","author":"Nishiwaki","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.intimp.2026.116780_bb1020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ. Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb1025","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12374","article-title":"Roles of \u03b1-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson's disease progression (Review)","volume":"24","author":"Lei","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb1030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb1035","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2015.1039691","article-title":"Microbiota and the control of blood-tissue barriers","volume":"3","author":"Al-Asmakh","year":"2015","journal-title":"Tissue. Barriers"},{"key":"10.1016\/j.intimp.2026.116780_bb1040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","article-title":"Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14","volume":"182","author":"Guo","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2026.116780_bb1045","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","article-title":"Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-\u03baB pathway through microbiota-gut-brain axis","volume":"11","author":"Zhao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2026.116780_bb1050","article-title":"Kaempferol attenuates LPS-induced striatum injury in mice involving anti-neuroinflammation, maintaining BBB integrity, and down-regulating the HMGB1\/TLR4 pathway","volume":"20","author":"Yang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.biopha.2017.08.132","article-title":"Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson\u2019s disease and cell culture via inactivating TLR4\/NF-\u03baB pathway","volume":"97","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116780_bb1060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/ptr.6307","article-title":"Farrerol attenuates MPP(+) -induced inflammatory response by TLR4 signaling in a microglia cell line","volume":"33","author":"Cui","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuro.2021.08.018","article-title":"Genkwanin suppresses MPP(+)-induced cytotoxicity by inhibiting TLR4\/MyD88\/NLRP3 inflammasome pathway in a cellular model of Parkinson's disease","volume":"87","author":"Li","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2026.116780_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147958","article-title":"Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement","volume":"1789","author":"Ishola","year":"2022","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1075","doi-asserted-by":"crossref","first-page":"3263446","DOI":"10.1155\/2022\/3263446","article-title":"Baicalin mitigates the neuroinflammation through the TLR4\/MyD88\/NF-\u03baB and MAPK pathways in LPS-stimulated BV-2 microglia","volume":"2022","author":"Li","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2026.116780_bb1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175517","article-title":"Silibinin chronic treatment in a rat model of Parkinson disease: a comprehensive in-vivo evaluation and in silico molecular modeling","volume":"941","author":"Eyvari Brooshghalan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.31083\/j.jin2310185","article-title":"Luteolin mitigates dopaminergic neuron degeneration and restrains microglial M1 polarization by inhibiting toll like receptor 4","volume":"23","author":"Xie","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb1090","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s11064-024-04099-8","article-title":"Orientin modulates Nrf2-ARE, PI3K\/Akt, JNK-ERK1\/2, and TLR4\/NF-kB pathways to produce neuroprotective benefits in Parkinson's disease","volume":"49","author":"Vasudevan Sajini","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12192-016-0695-3","article-title":"Curcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium ion (MPP(+))-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway","volume":"21","author":"Yu","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.intimp.2026.116780_bb1100","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1039\/D1FO02216D","article-title":"Neuroprotection of chicoric acid in a mouse model of Parkinson\u2019s disease involves gut microbiota and TLR4 signaling pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2026.116780_bb1105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5114\/fn.2023.131191","article-title":"Vanillin attenuates oxidative stress and neurochemical balance in MPTP-induced Parkinson's disease mice by regulating the TLR-4 inflammatory pathway","volume":"62","author":"Gao","year":"2024","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.intimp.2026.116780_bb1110","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102420","article-title":"Punicalagin\u2019s protective effects on Parkinson\u2019s progression in socially isolated and socialized rats: insights into multifaceted pathway","volume":"15","author":"Salem","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2026.116780_bb1115","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3233\/JAD-180330","article-title":"Diosgenin attenuates lipopolysaccharide-induced Parkinson's disease by inhibiting the TLR\/NF-\u03baB pathway","volume":"64","author":"Li","year":"2018","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.intimp.2026.116780_bb1120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10799893.2020.1767135","article-title":"Platycodin D inhibits MPP(+)-induced inflammatory response in BV-2 cells through the TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"40","author":"Sun","year":"2020","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156462","article-title":"Cycloastragenol targets Fpr2 to inhibit the TLR4\/NF-\u03baB signaling pathway and alleviate neuroinflammation in Parkinson's disease","volume":"139","author":"Xiao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2026.116780_bb1130","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1039\/D3FO05169B","article-title":"Gastrodia elata polysaccharide alleviates Parkinson\u2019s disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota","volume":"15","author":"Gan","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2026.116780_bb1135","article-title":"Fucoidan ameliorates rotenone-induced Parkinsonism in mice by regulating the microbiota-gut-brain axis","volume":"283","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116780_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119446","article-title":"A glucan from Ganoderma lucidum: Structural characterization and the anti-inflammatory effect on Parkinson's disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"343","author":"Chen","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1145","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fphar.2020.00776","article-title":"Oxymatrine attenuates dopaminergic neuronal damage and microglia-mediated neuroinflammation through cathepsin D-dependent HMGB1\/TLR4\/NF-\u03baB pathway in Parkinson's disease","volume":"11","author":"Gan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118391","article-title":"The TLR4\/NF-\u03baB\/NLRP3 and Nrf2\/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson's disease","volume":"333","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120132","article-title":"Novel mechanistic insights towards the repositioning of alogliptin in Parkinson\u2019s disease","volume":"287","author":"Safar","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuro.2023.03.002","article-title":"Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and \u03b1-synuclein expressions in rats","volume":"96","author":"Ishola","year":"2023","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2026.116780_bb1165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuro.2021.11.011","article-title":"Role of melatonin in TLR4-mediated inflammatory pathway in the MTPT-induced mouse model","volume":"88","author":"Yildirim","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2026.116780_bb1170","doi-asserted-by":"crossref","first-page":"9424582","DOI":"10.1155\/2021\/9424582","article-title":"Neuroprotective effect of ceftriaxone on MPTP-induced Parkinson's disease mouse model by regulating inflammation and intestinal microbiota","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2026.116780_bb1175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11481-021-10047-y","article-title":"Vancomycin pretreatment on MPTP-induced Parkinson's disease mice exerts neuroprotection by suppressing inflammation both in brain and gut","volume":"18","author":"Cui","year":"2023","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.116780_bb1185","article-title":"Inflammatory response modulation by vitamin C in an MPTP mouse model of Parkinson's disease","volume":"10","author":"De Nuccio","year":"2021","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.intimp.2026.116780_bb1190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","article-title":"Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson's disease, shifting M1 to M2 microglia responses","volume":"12","author":"Calvello","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.brainresbull.2021.06.024","article-title":"Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease","volume":"174","author":"Wang","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2026.116780_bb1200","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/ptr.6419","article-title":"Polyphenols: a concise overview on the chemistry, occurrence, and human health","volume":"33","author":"Durazzo","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/nu17152445","article-title":"Polyphenol intake from herbs and spices","volume":"17","author":"Blanton","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb1210","article-title":"Protective effects of polyphenol-rich extracts against neurotoxicity elicited by paraquat or rotenone in cellular models of Parkinson\u2019s disease","volume":"12","author":"Tambe","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.116780_bb1215","doi-asserted-by":"crossref","DOI":"10.3390\/nu15153454","article-title":"Polyphenols and their impact on the prevention of neurodegenerative diseases and development","volume":"15","author":"Grabska-Koby\u0142ecka","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb1220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054297","article-title":"Anti-inflammatory effects of flavonoids in common neurological disorders associated with aging","volume":"24","author":"Mart\u00ednez-Coria","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114537","article-title":"Flavonoids in the regulation of microglial-mediated neuroinflammation; focus on fisetin, rutin, and quercetin","volume":"447","author":"Jasim","year":"2025","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30091913","article-title":"Hepatoprotective effect of kaempferol-A review","volume":"30","author":"Nizi\u0144ski","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116780_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115215","article-title":"Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: from chemistry to medicine","volume":"165","author":"Jin","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116780_bb1240","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2026.116780_bb1245","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12951-024-02439-y","article-title":"The mitochondria-targeted Kaempferol nanoparticle ameliorates severe acute pancreatitis","volume":"22","author":"Wen","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2026.116780_bb1250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13880209.2021.2006723","article-title":"The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review","volume":"60","author":"Qin","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115159","article-title":"Genkwanin: An emerging natural compound with multifaceted pharmacological effects","volume":"165","author":"El Menyiy","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116780_bb1260","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2174\/0929867323666160106150821","article-title":"Morin: a promising natural drug","volume":"23","author":"Caselli","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111511","article-title":"Morin hydrate: a comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential","volume":"138","author":"Rajput","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116780_bb1270","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41401-020-0496-1","article-title":"Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes","volume":"42","author":"Liu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.116780_bb1275","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/cei\/uxac062","article-title":"Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPAR\u03b3\/LXR\u03b1 pathway","volume":"209","author":"Zhang","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb1280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jare.2024.02.023","article-title":"Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer","volume":"68","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1285","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin--new and emerging applications in medicine","volume":"14","author":"Gaz\u00e1k","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb1290","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.4049\/jimmunol.163.12.6800","article-title":"Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis","volume":"163","author":"Manna","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb1295","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1038\/s41598-018-21674-6","article-title":"Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats","volume":"8","author":"Tong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb1300","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jep.2018.05.019","article-title":"Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies","volume":"225","author":"Aziz","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1305","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41401-021-00702-8","article-title":"Luteolin alleviates cognitive impairment in Alzheimer\u2019s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation","volume":"43","author":"Kou","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.116780_bb1310","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1007\/s10787-025-01846-3","article-title":"Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NF\u0138B, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis","volume":"33","author":"Mahto","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2026.116780_bb1315","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10787-025-01690-5","article-title":"Orientin: a comprehensive review of a promising bioactive flavonoid","volume":"33","author":"Fahmy","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2026.116780_bb1320","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14264","article-title":"Health benefits of polyphenols: a concise review","volume":"46","author":"Rana","year":"2022","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.intimp.2026.116780_bb1325","doi-asserted-by":"crossref","first-page":"1233652","DOI":"10.3389\/fimmu.2023.1233652","article-title":"Curcumin derived from medicinal homologous foods: its main signals in immunoregulation of oxidative stress, inflammation, and apoptosis","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb1330","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10787-023-01136-w","article-title":"Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2026.116780_bb1335","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","article-title":"Therapeutic potential of curcumin in diabetic complications","volume":"136","author":"Parsamanesh","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1340","article-title":"Chicoric acid prevents neuroinflammation and neurodegeneration in a mouse Parkinson's disease model: immune response and transcriptome profile of the spleen and colon","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1345","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1111\/jcmm.14935","article-title":"Chicoric acid ameliorate inflammation and oxidative stress in Lipopolysaccharide and d-galactosamine induced acute liver injury","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107996","article-title":"Chicoric acid inhibits the initial attachment of IPEC-J2 cells by porcine epidemic diarrhea virus through the suppression of Akt phosphorylation","volume":"208","author":"Mao","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2026.116780_bb1355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031817","article-title":"Overview of the role of vanillin in neurodegenerative diseases and neuropathophysiological conditions","volume":"24","author":"Iannuzzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1360","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2174\/1389557519666190312164355","article-title":"Therapeutic potential of vanillin and its main metabolites to regulate the inflammatory response and oxidative stress","volume":"19","author":"Bezerra-Filho","year":"2019","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb1365","article-title":"Vanillin derivatives reverse fusobacterium nucleatum-induced proliferation and migration of colorectal cancer through E-cadherin\/\u03b2-catenin pathway","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1370","article-title":"Punicalagin regulates signaling pathways in inflammation-associated chronic diseases","volume":"11","author":"Xu","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.116780_bb1375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108476","article-title":"The role of punicalagin and its metabolites in atherosclerosis and risk factors associated with the disease","volume":"24","author":"Alalawi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114048","article-title":"Punicalagin inhibits neuron ferroptosis and secondary neuroinflammation to promote spinal cord injury recovery","volume":"148","author":"Wang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1385","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s11010-022-04478-1","article-title":"Punicalagin protects against the development of pancreatic injury and insulitis in rats with induced T1DM by reducing inflammation and oxidative stress","volume":"477","author":"Abdulhadi","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2026.116780_bb1390","doi-asserted-by":"crossref","DOI":"10.3390\/nu14234998","article-title":"Advances in the bioactivities of phytochemical saponins in the prevention and treatment of atherosclerosis","volume":"14","author":"Luo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb1395","article-title":"Advances in the biosynthesis and molecular evolution of steroidal saponins in plants","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1400","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10409238.2014.953628","article-title":"Metabolic and functional diversity of saponins, biosynthetic intermediates and semi-synthetic derivatives","volume":"49","author":"Moses","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.intimp.2026.116780_bb1405","doi-asserted-by":"crossref","first-page":"19838","DOI":"10.1021\/acs.jafc.4c04394","article-title":"Ginsenoside re prevents depression-like behaviors via inhibition of inflammation, oxidative stress, and activating BDNF\/TrkB\/ERK\/CREB signaling: an in vivo and in vitro study","volume":"72","author":"Chen","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb1410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13020-021-00424-3","article-title":"Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy","volume":"16","author":"Xu","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb1415","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/ptr.8432","article-title":"Natural saponins on cholesterol-related diseases: treatment and mechanism","volume":"39","author":"Xiao","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1420","doi-asserted-by":"crossref","DOI":"10.3390\/nu15163554","article-title":"Diosgenin targets CaMKK2 to alleviate type II diabetic nephropathy through improving autophagy, mitophagy and mitochondrial dynamics","volume":"15","author":"Zhong","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb1425","doi-asserted-by":"crossref","first-page":"1148853","DOI":"10.3389\/fphar.2023.1148853","article-title":"The pharmacology and mechanisms of platycodin D, an active triterpenoid saponin from Platycodon grandiflorus","volume":"14","author":"Xie","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2022.06.230","article-title":"The role of cycloastragenol at the intersection of NRF2\/ARE, telomerase, and proteasome activity","volume":"188","author":"Yilmaz","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb1435","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.joim.2024.05.004","article-title":"Cycloastragenol induces apoptosis and protective autophagy through AMPK\/ULK1\/mTOR axis in human non-small cell lung cancer cell lines","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb1440","article-title":"Cycloastragenol: a novel senolytic agent that induces senescent cell apoptosis and restores physical function in TBI-aged mice","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1445","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijbiomac.2016.06.100","article-title":"Bioactivities, isolation and purification methods of polysaccharides from natural products: a review","volume":"92","author":"Shi","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116780_bb1450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2018.02.084","article-title":"Characterization and antioxidant activities of polysaccharides from thirteen boletus mushrooms","volume":"113","author":"Zhang","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116780_bb1455","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.131586","article-title":"Interaction between polysaccharides and toll-like receptor 4: primary structural role, immune balance perspective, and 3D interaction model hypothesis","volume":"374","author":"Li","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb1460","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113374","article-title":"Diversity in chemical structures and biological properties of plant alkaloids","volume":"26","author":"Bhambhani","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116780_bb1465","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1021\/acschemneuro.4c00338","article-title":"Unlocking the potential of oxymatrine: a comprehensive review of its neuroprotective mechanisms and therapeutic prospects in neurological disorders","volume":"15","author":"Dhurandhar","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb1470","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/1673-5374.290879","article-title":"Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studies","volume":"16","author":"Giuliano","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1475","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41430-024-01411-1","article-title":"Effects of dietary supplements, foods, and dietary patterns in Parkinson's disease: meta-analysis and systematic review of randomized and crossover studies","volume":"78","author":"Wu","year":"2024","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.intimp.2026.116780_bb1480","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1080\/10408398.2021.1917508","article-title":"Absorption, metabolism and bioavailability of flavonoids: a review","volume":"62","author":"Chen","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.intimp.2026.116780_bb1485","doi-asserted-by":"crossref","first-page":"1667694","DOI":"10.3389\/fphar.2025.1667694","article-title":"Research progress on natural products in regulating the gut microbiota in Parkinson's disease","volume":"16","author":"Jia","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1490","doi-asserted-by":"crossref","first-page":"1496661","DOI":"10.3389\/fphar.2024.1496661","article-title":"Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies","volume":"15","author":"Wei","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1495","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010273","article-title":"Polyphenols and human health: the role of bioavailability","volume":"13","author":"Di Lorenzo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb1500","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/10408347.2022.2105641","article-title":"Bioactive flavonoids: a comprehensive review on pharmacokinetics and analytical aspects","volume":"54","author":"Billowria","year":"2024","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.intimp.2026.116780_bb1505","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jare.2025.01.014","article-title":"Flavonoids for gastrointestinal tract local and associated systemic effects: a review of clinical trials and future perspectives","volume":"77","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1510","article-title":"Botanical flavonoids: efficacy, absorption, metabolism and advanced pharmaceutical technology for improving bioavailability","volume":"30","author":"Hu","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116780_bb1515","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bcpt.14011","article-title":"Effects of quercetin in preclinical models of Parkinson\u2019s disease: a systematic review, Basic","volume":"135","author":"De Oliveira Vian","year":"2024","journal-title":"Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2026.116780_bb1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126484","article-title":"Preclinical pharmacokinetics-related pharmacological effects of orally administered polysaccharides from traditional Chinese medicines: a review","volume":"252","author":"Ye","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116780_bb1525","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijbiomac.2022.06.078","article-title":"Study on pharmacokinetics and tissue distribution of Polygonatum sibiricum polysaccharide in rats by fluorescence labeling","volume":"215","author":"Bi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116780_bb1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119653","article-title":"A lymphatic route for a hyperbranched heteroglycan from Radix Astragali to trigger immune responses after oral dosing","volume":"292","author":"Zhang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.intimp.2026.116780_bb1535","doi-asserted-by":"crossref","DOI":"10.1038\/s41538-026-00750-6","article-title":"Polysaccharides and the colon mucus barrier: a review of biophysical interactions and functional impacts","volume":"10","author":"Cheong","year":"2026","journal-title":"npj Sci. Food"},{"key":"10.1016\/j.intimp.2026.116780_bb1540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132170","article-title":"The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: a review","volume":"270","author":"Xue","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116780_bb1545","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1021\/acs.molpharmaceut.1c00090","article-title":"Administration routes of polyethylenimine-coated PLGA nanoparticles encapsulating angelica sinensis polysaccharide vaccine delivery system affect immune responses","volume":"18","author":"Gu","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2026.116780_bb1550","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.ijbiomac.2021.05.073","article-title":"Astragalus membranaceus polysaccharides potentiate the growth-inhibitory activity of immune checkpoint inhibitors against pulmonary metastatic melanoma in mice","volume":"182","author":"Hwang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116780_bb1555","doi-asserted-by":"crossref","first-page":"1393409","DOI":"10.3389\/fphar.2024.1393409","article-title":"Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review","volume":"15","author":"Ma","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1560","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.dmpk.2017.05.005","article-title":"Involvement of intestinal efflux and metabolic instability in the pharmacokinetics of platycodin D in rats","volume":"32","author":"Kwon","year":"2017","journal-title":"Drug. Metab. Pharmacokinet."},{"key":"10.1016\/j.intimp.2026.116780_bb1565","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jep.2015.04.056","article-title":"Effects of Gancao on pharmacokinetic profiles of platycodin D and deapio-platycodin D in Jiegeng","volume":"170","author":"Shan","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1570","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000497","article-title":"In vitro and in vivo evaluation of a water-in-oil microemulsion of platycodin D","volume":"354","author":"Shen","year":"2021","journal-title":"Arch. Pharm (Weinheim)"},{"key":"10.1016\/j.intimp.2026.116780_bb1575","doi-asserted-by":"crossref","DOI":"10.3390\/nu16101514","article-title":"Effects of saponins on lipid metabolism: the gut-liver axis plays a key role","volume":"16","author":"Cao","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116780_bb1580","article-title":"Exploring the lesser-known bioactive natural products of plant species of the Genus Cannabis L.: alkaloids, phenolic compounds, and their therapeutic potential","volume":"14","author":"Boucher","year":"2025","journal-title":"Plants (Basel)"},{"key":"10.1016\/j.intimp.2026.116780_bb1585","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114278","article-title":"The therapeutic importance of acid-base balance","volume":"183","author":"Quade","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1590","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17090469","article-title":"Bioorganic chemistry, toxinology, and pharmaceutical uses of datura metabolites and derivatives","volume":"17","author":"Thawabteh","year":"2025","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.intimp.2026.116780_bb1595","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.intimp.2026.116780_bb1600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116780_bb1605","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123307","article-title":"Alogliptin attenuates STZ-induced diabetic nephropathy in rats through the modulation of autophagy, apoptosis, and inflammation pathways: targeting NF-\u03baB and AMPK\/mTOR pathway","volume":"361","author":"Selim","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1610","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/pgmj.2008.067918","article-title":"Recent advances in the management of type 2 diabetes mellitus: a review","volume":"84","author":"Srinivasan","year":"2008","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.intimp.2026.116780_bb1615","doi-asserted-by":"crossref","first-page":"22489","DOI":"10.1038\/s41598-023-49870-z","article-title":"Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson\u2019s disease in diabetic patients","volume":"13","author":"Lin","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb1620","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179583","article-title":"Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases","volume":"23","author":"Diz-Chaves","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1625","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176635","article-title":"Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson's disease: unrevealing neurochemical and histopathological alterations in rodents","volume":"975","author":"Dhureja","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1630","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1734-1140(11)70574-6","article-title":"Role of vinpocetine in cerebrovascular diseases","volume":"63","author":"Patyar","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb1635","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1038\/s41598-017-11664-5","article-title":"Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells","volume":"7","author":"H\u00f6llerhage","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116780_bb1640","first-page":"325","article-title":"Melatonin: exceeding expectations","volume":"29","author":"Reiter","year":"2014","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.intimp.2026.116780_bb1645","article-title":"Neuroprotective effect of melatonin on sleep disorders associated with Parkinson's disease","volume":"12","author":"Hu","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.116780_bb1650","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.784314","article-title":"Melatonin treatment for sleep disorders in Parkinson's disease: a meta-analysis and systematic review","volume":"14","author":"Ma","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb1655","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3109\/10715762.2015.1027198","article-title":"Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model","volume":"49","author":"Ozsoy","year":"2015","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.intimp.2026.116780_bb1660","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QCO.0000000000000623","article-title":"Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia","volume":"33","author":"Paterson","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb1665","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JPD-212640","article-title":"Induction of Parkinsonian-like changes via targeted downregulation of astrocytic glutamate transporter GLT-1 in the striatum","volume":"12","author":"Ren","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb1670","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neubiorev.2020.05.016","article-title":"Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease","volume":"115","author":"Smaga","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2026.116780_bb1675","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.27077","article-title":"Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine Parkinson\u2019s disease model","volume":"32","author":"Chotibut","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116780_bb1680","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1685","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited - 60 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front. Public Health"},{"key":"10.1016\/j.intimp.2026.116780_bb1690","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27217319","article-title":"An overview of analytical methodologies for determination of vancomycin in human plasma","volume":"27","author":"Cheng","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116780_bb1695","article-title":"Gut microbiota: a novel therapeutic target for Parkinson's Disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116780_bb1700","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12264-023-01123-9","article-title":"Relationship between short-chain fatty acids and Parkinson\u2019s disease: a review from pathology to clinic","volume":"40","author":"Duan","year":"2024","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.intimp.2026.116780_bb1705","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41522-025-00780-0","article-title":"Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson\u2019s disease","volume":"11","author":"Villette","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.intimp.2026.116780_bb1710","doi-asserted-by":"crossref","first-page":"2284247","DOI":"10.1080\/19490976.2023.2284247","article-title":"Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design","volume":"15","author":"Cheng","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.intimp.2026.116780_bb1715","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.intimp.2026.116780_bb1720","article-title":"Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-na\u00efve Parkinson's disease: a randomized phase 2 trial","volume":"11","author":"Zhang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116780_bb1725","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal microbiota transplantation for treatment of Parkinson disease: a randomized clinical trial","volume":"81","author":"Scheperjans","year":"2024","journal-title":"JAMA. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb1730","doi-asserted-by":"crossref","first-page":"1639911","DOI":"10.3389\/fnins.2025.1639911","article-title":"Safety and efficacy of fecal microbiota transplantation in the treatment of Parkinson's disease: a systematic review of clinical trials","volume":"19","author":"Chen","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2026.116780_bb1735","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12883-025-04105-8","article-title":"Efficacy and safety of fecal microbiota transplantation in the management of parkinson\u2019s disease: a systematic review","volume":"25","author":"Nabil","year":"2025","journal-title":"BMC Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb1740","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41531-025-01061-5","article-title":"Faecal microbiota transplant in Parkinson\u2019s disease: pilot study to establish safety & tolerability","volume":"11","author":"De Sciscio","year":"2025","journal-title":"NPJ. Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2026.116780_bb1745","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-071766","article-title":"Safety and feasibility of faecal microbiota transplantation for patients with Parkinson\u2019s disease: a protocol for a self-controlled interventional donor-FMT pilot study","volume":"13","author":"Vendrik","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.intimp.2026.116780_bb1750","doi-asserted-by":"crossref","DOI":"10.3390\/biom9070271","article-title":"Role of dietary supplements in the management of Parkinson's disease","volume":"9","author":"Ciulla","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116780_bb1755","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031333","article-title":"Vitamins in the prevention and support therapy of neurodegenerative diseases","volume":"26","author":"Orywal","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116780_bb1760","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","article-title":"Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2","volume":"46","author":"Harrison","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2026.116780_bb1765","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","article-title":"Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial","volume":"75","author":"Schenkman","year":"2018","journal-title":"JAMA. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb1770","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.omtn.2022.03.005","article-title":"First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers","volume":"28","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2022","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.intimp.2026.116780_bb1775","doi-asserted-by":"crossref","first-page":"1127585","DOI":"10.3389\/fneur.2023.1127585","article-title":"APRIL: A double-blind, placebo-controlled, randomized, Phase Ib\/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke","volume":"14","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2026.116780_bb1780","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1785","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2026.116780_bb1790","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116780_bb1795","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107300","article-title":"Evaluation of curcumin as add-on therapy in patients with Parkinson\u2019s disease: A pilot randomized, triple-blind, placebo-controlled trial","volume":"218","author":"Ghodsi","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.intimp.2026.116780_bb1800","doi-asserted-by":"crossref","first-page":"1593191","DOI":"10.3389\/fphar.2025.1593191","article-title":"Curcumin as a potential therapeutic agent for Parkinson\u2019s disease: a systematic review","volume":"16","author":"Chang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116780_bb1805","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117862","article-title":"An update on drug repurposing in Parkinson's disease: preclinical and clinical considerations","volume":"183","author":"Salvad\u00e8","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116780_bb1810","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.sleep.2024.10.020","article-title":"Melatonin on sleep in Parkinson\u2019s disease: a randomized double blind placebo controlled trial","volume":"124","author":"Sugumaran","year":"2024","journal-title":"Sleep Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:56:57Z","timestamp":1789243017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926006260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":362,"alternative-id":["S1567576926006260"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116780","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116780"}}